品牌咨询
联系方式
公司地址
苏州工业园区生物纳米园A4#216
联系电话
4000-520-616 / 18915418616
传真号码
0512-67156496
电子邮箱
info@ebiomall.com
公司网址
https://www.ebiomall.com

Everest Biotech/Sorafenib Tosylate 5g/1100200053/5g

价格
¥4565.60
货号:1100200053
浏览量:127
品牌:Everest Biotech
服务
全国联保
正品保证
正规发票
签订合同
商品描述
MolecularFormula:C21H16ClF3N4O3•C7H8O3S
MolecularWeight:637.03g/mol
CASNumber:475207-59-1
Appearance:Offwhitepowder
Solubility:solubleinDMSOat200mg/mL;verypoorlysolubleinethanol
Storage:-20ºC
Purity:99%

MaterialSafetyDataSheet

Date:Oct22,2015

1.PRODUCTANDCOMPANYIDENTIFICATION

1.1Productidentifier:

Productname:SorafenibTosylate

CatalogNo:1100203002,1100205002,1100200013,1100200023,1100200053

1.2Relevantidentifiedusesofthesubstanceormixtureandusesadvisedagainst

Forresearchuseonly.

1.3Detailsofthesupplierofthesafetydatasheet

Company:EtonBioscienceInc

TollFree:1-800-758-1630

Tel:1-800-758-1630

Fax:1-800-507-2912

1.4Emergencytelephonenumber

1-800-758-1630

2.HAZARDSIDENTIFICATION

2.1Classificationofthesubstanceormixture

Notadangeroussubstanceormixture

2.2GHSLabelelements,includingprecautionarystatements

Notadangeroussubstanceormixture

2.3Otherhazards

None

3.COMPOSITION/INFORMATIONONINGREDIENTS

3.1Substances

MolecularFormula:C21H16ClF3N4O3•C7H8O3S

MolecularWeight:637.03g/mol

CASNo:475207-59-1

4.FIRSTAIDMEASURES

4.1Descriptionoffirstaidmeasures

Eyecontact

Checkforandremovecontactlensesandflushwithcopiousamountsofwater;assureadequateflushingbyseparatingtheeyelidswithfingers;callaphysician

SkinContact

flushwithcopiousamountsofwater;removecontaminatedclothingandshoes;callaphysician

Inhalation

Ifinhaled,removetofreshair;ifbreathingisdifficult,giveoxygen;ifbreathingstops,giveartificialrespiration

Ingestion

ifswallowed,washoutmouthwithcopiousamountsofwater.DONOTinducevomiting.Callaphysician

4.2Mostimportantsymptomsandeffects,bothacuteanddelayed

Noinformationavailable

4.3Indicationofanyimmediatemedicalattentionandspecialtreatmentneeded.

Noinformationavailable



5.FIREFIGHTINGMEASURES

5.1Extinguishingmedia

Suitableextinguishingmedia

waterspray,carbondioxide,drychemicalpowderorfoam

5.2Specialhazardsarisingfromthesubstanceormixture

Noinformationavailable

5.3Adviceforfirefighters

Wearself-containedbreathingapparatusandprotectiveclothingtopreventcontactwithskinandeyes.

6.ACCIDENTALRELEASEMEASURES

6.1Personalprecautions,protectiveequipmentandemergencyprocedures

Usefullpersonalprotectiveequipment.Evacuatepersonneltosafeareas.

6.2Environmentalprecautions

Preventfurtherleakageorspillage.Preventproductfromenteringdrain.

6.3Methodsandmaterialforcontainmentandcleaningup

Absorbsolutionswithfinely-powderedliquid-bindingmaterial(diatomite,universalbinders);decontaminatesurfacesandequipmentbyscrubbingwithalcohol;disposeofcontaminatedmaterialaccordingtoSection13

7.HANDLINGANDSTORAGE

7.1Precautionsforsafehandling

Avoidskin/eyecontact.Useprotectiveequipmentasneeded.Washcontaminatedclothingbeforereuse.

7.2Conditionsforsafestorage,includinganyincompatibilities

Keepcontainertightlyclosedinacool,well-ventedplace.Storeat-20˚C.

7.3Specificenduse(s)

Nodataavailable.

8.EXPOSURECONTROLS/PERSONALINFORMATION

8.1ControlParameters

Thisproductcontainsnohazardousmaterialswithoccupationalexposurelimits.

8.2Exposurecontrols

Engineeringcontrols

Provideshowerandeyewashstation

Personalprotectiveequipment

EyeProtection

Wearsafetygoggles

SkinProtection

Wearprotectiveclothing

HandProtection

Wearprotectivegloves

Respiratoryprotection

WearNIOSH/MSHAapprovedrespirators

9.PHYSICALANDCHEMICALPROPERTIES

9.1Informationonbasicphysicalandchemicalproperties

Appearance

Solid

pH

Nodataavailable

Meltingpoint

Nodataavailable

Freezingpoint

Nodataavailable

Boilingpoint

Nodataavailable

Density

Nodataavailable

Watersolubility

Verypoorlysoluble

9.2Othersafetyinformation

Nodataavailable.

10.STABILITYANDREACTIVITY

10.1Reactivity

Nodataavailable

10.2Chemicalstability

Stableunderrecommendedstorageconditions.

10.3Possibilityofhazardousreactions

Nodataavailable.

10.4Conditionstoavoid

Protectfromlightandheat

10.5IncompatIBLematerials

Strongoxidizingagents

10.6Hazardousdecompositionproducts

Thermaldecompositionmayproducetoxicgasessuchascarbonmonoxide,carbondioxide,andnitrogenoxides

11.TOXICOLOGICALINFORMATION

11.1Informationontoxicologicaleffects

Toxicologicaleffectsonthisproducthavenotbeenthoroughlystudied.

12.ECOLOGICALINFORMATION

12.1Toxicity

Avoidreleaseintoenvironment

12.2Persistenceanddegradability

Nodataavailable

12.3.Bioaccumlativepotential

Nodataavailable

12.4Mobilityinsoil

Nodataavailable

12.5ResultsofPBTandvPvBassessment

Nodataavailable

12.6Otheradverseeffects

Nodataavailable

13.DISPOSALINFORMATION

13.1Wastetreatmentmethods

Disposeinaccordancewithlocal,state,andfederalregulations.

14.TRANSPORTINFORMATION

DOT:
Propershippingname:none
Non-Hazardousfortransport:thissubstanceisconsideredtobenon-hazardousfortransport
IATA:
Propershippingname:none
Non-Hazardousfortransport:thissubstanceisconsideredtobenon-hazardousfortransport

IMDG:
Propershippingname:none
Non-Hazardousfortransport:thissubstanceisconsideredtobenon-hazardousfortransport

15.REGULATORYINFORMATION

EURiskandSafetyphrases:

R22:Harmfulifswallowed

S22:Donotbreathedust

S24/25:Avoidcontactwithskinandeyes

S26:Incaseofcontactwitheyes,rinseimmediatelywithplentyofwaterandseekmedicaladvice

S28:aftercontactwithskin,washimmediatelywithplentyofwater

S36/37/39:Wearsuitableprotectiveclothing,glovesandeye/faceprotection

16.OTHERINFORMATION

Theinformationaboveisbelievedtobeaccurateandrepresentsthebestinformationcurrentlyavailabletous.However,wemakenowarrantyofmerchantabilityoranyotherwarranty,expressorimplied,withrespecttosuchinformation.EtonBioscienceInc.shallnotbeheldliableforanydamagesorotherconsequencesresultingfromhandlingorfromcontactwiththeaboveproduct.

M.DanielleBareford,MargaretA.Park,AdlyYacoub,HosseinA.Hamed,YongTang,NicholaCruickshanks,PatrickEulitt,NisanHubbard,GaryTye,MatthewE.Burow,PaulB.Fisher,RichardG.Moran,KennethP.Nephew,StevenGrant,andPaulDent.:SorafenibEnhancesPemetrexedCytotoxicitythroughanAutophagy-DependentMechanisminCancerCells.CancerRes.,Jul2011;71:4955-4967.

EulittPJ,ParkMA,HosseinH,CruikshanksN,YangC,DmitrievIP,YacoubA,CurielDT,FisherPB,DentP.Enhancingmda-7/IL-24therapyinrenalcarcinomacellsbyinhibitingmultipleprotectivesignalingpathwaysusingsorafenibandbyAd.5/3genedelivery.CancerBiolTher.2011Jan12;10(12):1290-305.Epub2010Dec15.
Benedict,Ashwinietal.“RepurposingFDA-ApprovedDrugsasTherapeuticstoTreatRiftValleyFeverVirusInfection.”FrontiersinMicroBIOLOGy6(2015):676.PMC.Web.6Oct.2015.
Bareford,M.Danielleetal.“SorafenibandPemetrexedToxicityinCancerCellsIsMediatedviaSRC-ERKSignaling.”CancerBiology&Therapy13.9(2012):793–803.PMC.Web.6Oct.2015.


Everest Biotech自2000年以来,我们一直是抗肽和抗原亲和纯化山羊多克隆抗体的专家。我们的抗体具有100%的满意保证-它们可在您的实验室或您的退款中发挥作用。 LifeSpan BioSciences,Inc.收购了Everest Biotech。 在此处查找使用Everest抗体的最新出版物盖玻片  用于悬浮细胞免疫荧光 
  • 资质认证

    获得国家资质,权威认证!

  • 全国联保

    全国联保,官方无忧售后

  • 正规发票

    正规发票,放心购买

  • 签订合同

    签订合同,保障您的权益

/**/